Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors.

Claisen-Schmidt condensation of 3-formyl-9-methylcarbazole with various amides of 3-aminoacetophenone afforded N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives. All compounds were investigated for their in vitro xanthine oxidase (XO), tyrosinase and melanin production inhibitory activity. Most of the target compounds had more potent XO inhibitory activity than the standard drug (IC(50) = 4.3-5.6 μM). Interestingly, compound 7q bearing cyclopropyl ring was found to be the most potent inhibitor of XO (IC(50) = 4.3 μM). Molecular modelling study gave an insight into its binding modes with XO. Compounds 7a, 7d, 7e, 7g, and 7k were found to be potent inhibitors of tyrosinase (IC(50) = 14.01-17.52 μM). These results suggest the possible use of these compounds for the design and development of novel XO and tyrosinase inhibitors.

[1]  E. Pai,et al.  The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Yamanaka,et al.  Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. , 2000, Journal of epidemiology.

[3]  J. Vaya,et al.  Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. , 2005, Bioorganic & medicinal chemistry.

[4]  E. Niki,et al.  Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation. , 2000, Biochemical pharmacology.

[5]  Chung-Yi Chen,et al.  (-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant. , 2010, Bioorganic & medicinal chemistry.

[6]  Y. Martin,et al.  A general and fast scoring function for protein-ligand interactions: a simplified potential approach. , 1999, Journal of medicinal chemistry.

[7]  Takahiko Nakagawa,et al.  A causal role for uric acid in fructose-induced metabolic syndrome. , 2006, American journal of physiology. Renal physiology.

[8]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[9]  H. Inoue,et al.  Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors. , 2001, Bioorganic & medicinal chemistry letters.

[10]  M. Ichihashi,et al.  Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. , 2007, The Journal of investigative dermatology.

[11]  M. Becker,et al.  Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. , 2005, Life sciences.

[12]  Ingo Muegge,et al.  Evaluation of docking/scoring approaches: A comparative study based on MMP3 inhibitors , 2000, J. Comput. Aided Mol. Des..

[13]  Matthias Rarey,et al.  Small Molecule Docking and Scoring , 2001 .

[14]  B. Bandgar,et al.  Synthesis and biological evaluation of orally active prodrugs of indomethacin. , 2011, Journal of medicinal chemistry.

[15]  Shosuke Ito,et al.  A Chemist's View of Melanogenesis , 2003 .

[16]  John R. Whitaker,et al.  The biochemistry and control of enzymatic browning , 1995 .

[17]  Raj Kumar,et al.  A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors. , 2011, Bioorganic & medicinal chemistry.

[18]  J. Allalunis-Turner,et al.  The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition , 2009, Breast Cancer Research.

[19]  Jen-kun Lin,et al.  Molecular modeling of flavonoids that inhibits xanthine oxidase. , 2002, Biochemical and biophysical research communications.

[20]  Xu Liu,et al.  3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor. , 2011, Chemico-biological interactions.

[21]  W. Dröge.  Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[22]  Z. Wen,et al.  Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase , 2011, Experimental dermatology.

[23]  Raj Kumar,et al.  N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors. , 2011, Bioorganic & medicinal chemistry.

[24]  L. Meijer,et al.  Synthesis and biological evaluation of novel phenylcarbazoles as potential anticancer agents. , 2006, Journal of medicinal chemistry.

[25]  R. Hille,et al.  Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin. , 2009, Journal of natural products.

[26]  Jian-Dong Jiang,et al.  Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors. , 2006, Journal of medicinal chemistry.

[27]  P. Hajduk,et al.  Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. , 1999, Journal of medicinal chemistry.

[28]  M D Harris,et al.  Gout and hyperuricemia. , 1999, American family physician.

[29]  Ikuko Miyazaki,et al.  Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease , 2009, Neurotoxicity Research.

[30]  K. Baumann,et al.  NSAID-derived γ-secretase modulation requires an acidic moiety on the carbazole scaffold. , 2011, Bioorganic & medicinal chemistry.

[31]  K. Hande,et al.  Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. , 1984, The American journal of medicine.

[32]  Y. Kitamura,et al.  Hydroxychavicol: a potent xanthine oxidase inhibitor obtained from the leaves of betel, Piper betle , 2009, Journal of Natural Medicines.

[33]  T. Jansen,et al.  Management of hyperuricemia in gout: focus on febuxostat , 2010, Clinical interventions in aging.

[34]  H. Knölker,et al.  Isolation and synthesis of biologically active carbazole alkaloids. , 2002, Chemical reviews.